CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $199,000 | -43.9% | 47,245 | -33.7% | 0.00% | -100.0% |
| Q1 2021 | $355,000 | +181.7% | 71,239 | +422.0% | 0.00% | – |
| Q4 2019 | $126,000 | -58.7% | 13,648 | -45.9% | 0.00% | – |
| Q1 2019 | $305,000 | -80.5% | 25,240 | -79.7% | 0.00% | -100.0% |
| Q4 2018 | $1,561,000 | -56.9% | 124,394 | -49.0% | 0.00% | -33.3% |
| Q3 2018 | $3,622,000 | -20.1% | 244,081 | -9.3% | 0.00% | -40.0% |
| Q2 2018 | $4,531,000 | -49.0% | 269,188 | -30.6% | 0.01% | -50.0% |
| Q1 2018 | $8,879,000 | +110.9% | 387,748 | +138.3% | 0.01% | +150.0% |
| Q4 2017 | $4,210,000 | +2651.6% | 162,739 | +976.0% | 0.00% | – |
| Q3 2016 | $153,000 | -63.7% | 15,125 | -59.6% | 0.00% | -100.0% |
| Q2 2016 | $421,000 | -53.8% | 37,469 | -43.9% | 0.00% | -50.0% |
| Q1 2016 | $912,000 | -55.6% | 66,786 | -38.3% | 0.00% | -50.0% |
| Q4 2015 | $2,054,000 | -30.8% | 108,276 | -31.5% | 0.00% | -33.3% |
| Q3 2015 | $2,967,000 | +532.6% | 158,081 | +401.9% | 0.01% | +500.0% |
| Q2 2015 | $469,000 | – | 31,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |